76142 GLP-1 receptor agonists and reduced risk of melanoma and nonmelanoma skin cancer (NMSC): A retrospective cohort study of patients with obesity
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB235
DOI: 10.1016/j.jaad.2026.04.951 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Rashwan Alameddine und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alameddine, R., Roecker, A., Jabin, M., Ahatov, R., & Wagner, R. F. (2026). 76142 GLP-1 receptor agonists and reduced risk of melanoma and nonmelanoma skin cancer (NMSC): A retrospective cohort study of patients with obesity. Journal of the American Academy of Dermatology, 95(1), AB235. https://doi.org/10.1016/j.jaad.2026.04.951
Vancouver
Alameddine R, Roecker A, Jabin M, Ahatov R, Wagner RF. 76142 GLP-1 receptor agonists and reduced risk of melanoma and nonmelanoma skin cancer (NMSC): A retrospective cohort study of patients with obesity. Journal of the American Academy of Dermatology. 2026;95(1):AB235. doi:10.1016/j.jaad.2026.04.951
BibTeX
@article{Alameddine2026,
author = {Alameddine, Rashwan and Roecker, Allison and Jabin, Mohamad and Ahatov, Renat and Wagner, Richard F.},
title = {76142 GLP-1 receptor agonists and reduced risk of melanoma and nonmelanoma skin cancer (NMSC): A retrospective cohort study of patients with obesity},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB235},
doi = {10.1016/j.jaad.2026.04.951}
}
EUVIMED